afachemi.com
Afachemi Pharmaceutical Company is an Iranian manufacturer of oral and injectable antibiotic and non-antibiotic medications, serving hospitals, physicians, pharmacies, and patients across Iran through 500+ distributors and 8+ GMP-compliant production lines as a subsidiary of Nophico Holding.
- Company typePrivate
- Founded1978
- HeadquartersTehran, Iran
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What afachemi.com does
Afachemi Pharmaceutical Company (شرکت داروسازی آفاشیمی) is an Iranian pharmaceutical manufacturer headquartered in Tehran that produces oral and injectable antibiotic and non-antibiotic medications for the domestic Iranian market. Founded in 1978 as a cosmetics and hygiene products company, Afachemi pivoted into pharmaceuticals in 2001, launched oral antibiotic production (cephalosporins and penicillins) under GMP standards in 2007, and entered sterile injectable manufacturing (cephalosporin and carbapenem vials) in 2013, followed by general sterile vial production in 2017. It operates as a subsidiary of Nophico Holding (هلدینگ نوفیکو), described as Iran's largest private pharmaceutical holding company, which oversees 800+ products across 65+ therapeutic categories and exports to Central Asia, Africa, and the Middle East.
afachemi.com firmographics
Firmographics- Name
- afachemi.com
- Legal name
- AFA CHEMI PHARMACEUTICAL Co.
- Website
- https://afachemi.com
- Company type
- Private
- Founded year
- 1978
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Afachemi Pharmaceutical Company is an Iranian manufacturer of oral and injectable antibiotic and non-antibiotic medications, serving hospitals, physicians, pharmacies, and patients across Iran through 500+ distributors and 8+ GMP-compliant production lines as a subsidiary of Nophico Holding.
- Ownership category
- akta.pro rank
afachemi.com industry classification
Industry- Product category
- Generic Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Infectious Disease & Antimicrobials Pharmaceuticals (HLAIAAAG)
- akta.pro secondary industries
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA), Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)
Keywords
Where afachemi.com is headquartered
LocationHeadquarters
- HQ city
- Tehran
- HQ country
- Iran
- HQ region
- Middle East
Offices1 record
Markets served
afachemi.com business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical Product Sales: Afachemi generates revenue through the manufacture and sale of pharmaceutical products including antibiotics (cephalosporins, penicillins, carbapenems) in oral and injectable forms, as well as non-antibiotic medications. Products are distributed domestically across Iran through a network of over 500 distributors and directly to healthcare providers.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
afachemi.com product offering
Product offeringCore offering
Afachemi Pharmaceutical Company manufactures oral and injectable antibiotic (cephalosporins, penicillins, carbapenems) and non-antibiotic pharmaceutical products at its GMP-compliant facility in Tehran, Iran. The company operates more than 8 production lines equipped with Bosch (Germany) automated machinery and produces sterile injectable vials under dedicated contamination-controlled sections. Its portfolio of 100+ products is distributed domestically through a network of 500+ active distributors and reaches 17,000+ indirect customers across all Iranian provinces.
Product overview
Afachemi Pharmaceutical Company is a pharmaceutical manufacturer producing antibiotic and non-antibiotic medications in both oral and injectable forms. The company operates under Nophico Holding and produces injectable and oral cephalosporins, oral penicillins, injectable carbapenems, and general non-antibiotic products including cardiovascular drugs (Clopidogrel, Esomeprazole), osteoporosis treatments (Alendronate), erectile dysfunction treatments (Sildenafil), antidepressants (Venlafaxine), anti-obesity drugs (Orlistat), antihistamines (Desloratadine, Cinnarizine), and anti-inflammatory medications (Indomethacin, Doxycycline, Rifampin). The production facilities include cephalosporin and penicillin oral production sections and injectable vial production units, all equipped with Bosch machinery and operating under GMP standards.
Differentiator
Problem solved
Functional benefit
Products and services
- Afagra 50,100 (آفاگرا)
Quantifiable outcome
- 100+ pharmaceutical products manufactured and distributed across Iran
- +2 more outcomes
Companies that use afachemi.com
Customer profileNamed customers5 records
Segments2 records
Ideal customer profiles2 records
afachemi.com technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
afachemi.com partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- Nophico Holding (هلدینگ نوفیکو)coreAfachemi is a subsidiary of Nophico Holding, Iran's largest private pharmaceutical holding. Nophico supervises Afachemi's formulation development and strategic direction. The holding produces 800+ pharmaceutical products across 65+ therapeutic categories and exports to Central Asia, Africa, Middle East, and neighboring countries.
- Hejrat Co.minorHejrat Co. is one of Afachemi's pharmaceutical distribution partners serving customers across Iran.
- Ferdows DCminorFerdows DC is a pharmaceutical distribution partner for Afachemi products across Iran.
- Nokhbegan DCminorNokhbegan DC is a pharmaceutical distribution partner for Afachemi products across Iran.
- Alborz DCminorAlborz DC is a pharmaceutical distribution partner for Afachemi products across Iran.
- Ministry of Health of KyrgyzstanminorOfficials from the Ministry of Health of Kyrgyzstan visited Afachemi's production facilities, including the Director General of Drug Importation. The visit demonstrated international regulatory interest in Afachemi's GMP-compliant pharmaceutical manufacturing capabilities.
- Iraqi Pharmaceutical CompaniesminorRepresentatives from Iraqi pharmaceutical companies visited Afachemi's production line, indicating potential international market expansion and export opportunities.
- Ministry of Health and Welfare of KoreaminorSenior officials from the Ministry of Health and Welfare of Korea visited Afachemi's production facilities, demonstrating international interest in Iranian pharmaceutical manufacturing standards.
- Azerbaijan Health OfficialsminorSenior officials from Azerbaijan conducted meetings and visits to Afachemi's production facilities, indicating potential international collaboration and export opportunities.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
afachemi.com competitors and assessment
Company assessmentDirect peers
- Loghman Pharmaceutical & Hygienic Company: Iranian finished-dose pharmaceutical manufacturer producing oral and injectable products across multiple therapeutic categories. Comparable in product breadth, GMP manufacturing model, and domestic distribution.
- Cipla: Major Indian generic pharmaceutical company with broad finished-dose-form and sterile injectable capabilities, including antibiotics and cardiovascular/respiratory products overlapping Afachemi's non-antibiotic portfolio.
- TPICO (Tehran Pharma): Iranian pharmaceutical manufacturer producing generic oral and injectable finished dosage forms with GMP-compliant facilities and domestic distribution. Directly comparable peer in product mix, regulatory environment, and target market.
- Hikma Pharmaceuticals: MENA-focused specialty pharmaceutical manufacturer with a strong generics and injectable portfolio across the Middle East and North Africa. Comparable to Afachemi in therapeutic breadth, sterile injectable capability, and regional market focus.
- Darou Pakhsh Pharma: Iran's largest pharmaceutical manufacturer, producing a broad portfolio of finished-dose generics and antibiotics across oral and injectable forms. Most directly comparable domestic peer to Afachemi in terms of product category, GMP-manufacturing model, and Iran-wide distribution.
- Aurobindo Pharma: Large Indian generic manufacturer with a heavy concentration in beta-lactam antibiotics (cephalosporins, penicillins) and sterile injectables. Closest international analogue to Afachemi's antibiotic-heavy, finished-dose-form manufacturing model.
- Darou Pars: Iranian pharmaceutical company producing generic oral and injectable medications with GMP certification and nationwide distribution. Direct peer operating in the same regulatory and market environment as Afachemi.
Broad incumbents
- Sun Pharmaceutical Industries: One of the world's largest generic pharmaceutical manufacturers with broad specialty and sterile injectable capabilities. Comparable in finished-dose-form manufacturing scale and antibiotic/non-antibiotic product breadth, but operates at significantly larger scale globally.
- Dr. Reddy's Laboratories: Global Indian pharmaceutical manufacturer with substantial generic and sterile injectable portfolio across antibiotics and other therapeutic categories. Comparable in product category breadth, though at much larger scale and with global commercial reach.
Regional players
- Sobhan Oncology: Iranian pharmaceutical manufacturer with GMP-certified injectable production capabilities. Comparable as a regional peer with sterile injectable infrastructure, though more focused on oncology-related products than Afachemi's broader therapeutic mix.
Market position
Strengths1 record
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
afachemi.com social profiles
Digital presenceafachemi.com compliance and trust
Trust signalCompliance8 records
afachemi.com financial estimates
Financial estimateRevenue estimate
Valuation estimate
afachemi.com leadership team
Management profileNumber of profiles
Profiles12 records
afachemi.com funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
afachemi.com M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about afachemi.com
What does afachemi.com do?
Afachemi Pharmaceutical Company manufactures oral and injectable antibiotic (cephalosporins, penicillins, carbapenems) and non-antibiotic pharmaceutical products at its GMP-compliant facility in Tehran, Iran. The company operates more than 8 production lines equipped with Bosch (Germany) automated machinery and produces sterile injectable vials under dedicated contamination-controlled sections. Its portfolio of 100+ products is distributed domestically through a network of 500+ active distributors and reaches 17,000+ indirect customers across all Iranian provinces.
Is afachemi.com a public or private company?
afachemi.com is a private company. It is classified as corporate owned and is currently operating.
When was afachemi.com founded?
afachemi.com was founded in 1978. It employs 1 to 10 people.
Where is afachemi.com based?
afachemi.com is headquartered in Tehran, Iran, in the Middle East region.
How does afachemi.com make money?
One revenue line is on record: pharmaceutical Product Sales.
Who are afachemi.com's main competitors?
Direct peers on record are Loghman Pharmaceutical & Hygienic Company, Cipla, TPICO (Tehran Pharma), Hikma Pharmaceuticals, Darou Pakhsh Pharma, Aurobindo Pharma and Darou Pars. Broad incumbents are Sun Pharmaceutical Industries and Dr. Reddy's Laboratories. Sobhan Oncology is listed as a regional player.
Does afachemi.com have an API?
No public API is recorded for afachemi.com.
What industry is afachemi.com in?
afachemi.com's product category is Generic Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAG, Infectious Disease & Antimicrobials Pharmaceuticals, with a secondary code of HLAIAAAA, Primary Care & General Medicine Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.